Sanchez-Ramos Luis, Olivier Felicia, Delke Isaac, Kaunitz Andrew M
Department of Obstetrics and Gynecology, University of Florida, Jacksonville, Florida, USA.
Obstet Gynecol. 2003 Jun;101(6):1312-8. doi: 10.1016/s0029-7844(03)00342-9.
To compare routine labor induction with expectant management for patients who reach or exceed 41 weeks' gestation.
Computerized databases, references in published studies, and textbook chapters in all languages were used to identify randomized controlled trials (RCTs) evaluating induction and expectant management of labor for postterm pregnancies.
We identified RCTs that compared induction and expectant management for uncomplicated, singleton, live pregnancies of at least 41 weeks' gestation and evaluated at least one of the following: perinatal mortality, mode of delivery, meconium-stained fluid, meconium aspiration syndrome, meconium below the cords, fetal heart rate (FHR) abnormalities during labor, cesarean deliveries for FHR abnormalities, abnormal Apgar scores, and neonatal intensive care unit (NICU) admissions. The primary outcomes assessed were cesarean delivery rate and perinatal mortality.
TABULATION, INTEGRATION, AND RESULTS: Sixteen studies met inclusion criteria for this review. For each study with binary outcomes, an odds ratio (OR) with 95% confidence intervals (CIs) was calculated for selected outcomes. Estimates of ORs for dichotomous outcomes were calculated using fixed and random-effects models. Homogeneity was tested across the studies. Compared with women allocated to expectant management, those who underwent labor induction had lower cesarean delivery rates (20.1% versus 22.0%) (OR 0.88; 95% CI 0.78, 0.99). Although subjects whose labor was induced experienced a lower perinatal mortality rate (0.09% versus 0.33%) (OR 0.41; 95% CI 0.14, 1.18), this difference was not statistically significant. Similarly, no significant differences were noted for NICU admission rates, meconium aspiration, meconium below the cords, or abnormal Apgar scores.
A policy of labor induction at 41 weeks' gestation for otherwise uncomplicated singleton pregnancies reduces cesarean delivery rates without compromising perinatal outcomes.
比较对妊娠达到或超过41周的患者进行常规引产与期待治疗的效果。
利用计算机数据库、已发表研究中的参考文献以及所有语言的教科书章节,来识别评估过期妊娠引产和期待治疗的随机对照试验(RCT)。
我们确定了比较引产与期待治疗的RCT,这些试验针对孕周至少为41周的无并发症单胎活产妊娠,并且评估了以下至少一项指标:围产期死亡率、分娩方式、羊水粪染、胎粪吸入综合征、脐带以下有胎粪、产程中胎儿心率(FHR)异常、因FHR异常而行剖宫产、阿氏评分异常以及新生儿重症监护病房(NICU)收治情况。评估的主要结局指标是剖宫产率和围产期死亡率。
制表、整合与结果:16项研究符合本综述的纳入标准。对于每项有二元结局的研究,针对选定结局计算了比值比(OR)及95%置信区间(CI)。采用固定效应模型和随机效应模型计算二分结局的OR估计值。对各项研究进行了同质性检验。与分配至期待治疗组的女性相比,接受引产的女性剖宫产率较低(20.1%对22.0%)(OR 0.88;95%CI 0.78,0.99)。虽然引产的受试者围产期死亡率较低(0.09%对0.33%)(OR 0.41;95%CI 0.14,1.18),但这种差异无统计学意义。同样,在NICU收治率、胎粪吸入、脐带以下有胎粪或阿氏评分异常方面未发现显著差异。
对于其他方面无并发症的单胎妊娠,在妊娠41周时进行引产的策略可降低剖宫产率,且不影响围产期结局。